期刊文献+

K562/ADR细胞的5型腺病毒感染率研究

Research on the Infection Efficiency of Ad5 in K562/ADR
下载PDF
导出
摘要 腺病毒是目前肿瘤基因治疗研究的常用载体,而5型腺病毒(Ad5)以其复制效率高、载体容量大等优势而被广泛用于基因治疗的相关研究。比较5型腺病毒对人白血病细胞K562及其耐药株K562/ADR的感染效率,并分析引起这种差异的分子机制。流式细胞术及荧光显微镜观察,结果显示,5型腺病毒对K562/ADR的感染效率明显高于K562;Real time PCR定量分析表明K562/ADR细胞株表面的CAR表达水平约为K562的1.33倍(P<0.05),而整合素αν表达则是K562的4.36倍(P<0.01)。 Adenovirus is a commonly used vector in research of cancer gene therapy at present, while the adenovirus type 5 (ADS) has been widely used for its high replication efficiency and high capacity. In this paper, the infection efficiency of adenovirus type 5 is compared in human leukemia cell K562 and the drug-resistant cell strain K562/ADR, and analyzes the molecular mechanism that causes this difference. The results of flow cytometry and fluorescence microscope photographs both show the phenomena that the infection efficiency of adenovirus type 5 in K562/ADR is higher than that in K562, In addition, the CAR level in K562/ADR is about 1.33 times of that in K562 (P〈0.05), and the expression level of integrin av is 4. 36 times of that in K562 (P〈0.01).
出处 《浙江理工大学学报(自然科学版)》 2010年第5期795-798,804,共5页 Journal of Zhejiang Sci-Tech University(Natural Sciences)
基金 国家自然科学基金(30800093) 浙江省重中之重学科开放基金资助(SWYX0821)
关键词 5型腺病毒 K562 K562/ADR CAR 整合素αν adenovirus type 5 K562 K562/ADR CAR integrin av
  • 相关文献

参考文献2

二级参考文献19

  • 1LeiLI,Da-linHE.Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells[J].Acta Pharmacologica Sinica,2005,26(5):610-615. 被引量:5
  • 2Deiniger M W,Goldman J M,Melo J V,et al.The molecular biology of chronic myeloid leukemia.Blood,2000,96:3343-3356.
  • 3陈钰.慢性粒细胞性白血病的研究进展.沈志祥,主编.2002血液病学新进展.北京:人民卫生出版社,2002.70-71.
  • 4Clark R E.Antisense therapeutics in chronic myeloid leukemia:the promise,the progress and the problem.Leukemia,2000,14:347-355.
  • 5Luger S M,O'Brien S G,Ratajczak J,et al.Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow:A pilot study.Blood,2002,99:1150-1158.
  • 6Braasch D A,Corey D R.Novel antisense and peptide nucleic acid strategies for controlling gene expression.Biochemistry,2002,41:4503 -4510.
  • 7Scherr M,Battmer K,Winkler T,et al.Specific inhibition of bcr-abl gene expression by small interfering RNA.Blood,2003,101:1566-1569.
  • 8Tanabe T,Kuwnbara T,Warashina M,et al.Oncogene inactivation in a mouse model.Nature,2003,406:473 -474.
  • 9Kantarjian H,Sawgerse C,Hochhaus A,et al.Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogeneous leukemia.N Eng J Med,2002,346:645-652.
  • 10Talpaz M,Silver R T,Druker B J,et al.Imatinib induces durable hematologic and cytogenetic response in patients with accelerated phase chronic myeloid leukemia:Result of a phase Ⅱ study.Blood,2002,99:1928-1937.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部